AstraZeneca : AZN

All AstraZeneca Articles

218 Articles

Jon C. Ogg | Jul 12, 2016 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Accenture, Cognizant Tech, Fitbit, Oracle, Seagate, Vodafone and Many More

The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Accenture, Cognizant Technology Solutions, Fitbit, Oracle, Seagate Technology…

Jon C. Ogg | Jun 17, 2016 at 12:10 PM EDT

10 Stocks to Win or Lose From Brexit Vote Outcome

[cnxvideo id=”507734″ placement=”ros”]Perhaps the move for a rapid exit by Britain from the European Union (or Brexit) may have been…

Chris Lange | May 19, 2016 at 10:20 AM EDT

8 Stocks on the Move After ASCO Cancer Abstracts

ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or…

Chris Lange | May 8, 2016 at 9:45 AM EDT

4 Major FDA Decisions Expected by June

Several big FDA decisions should be coming up in the June quarter for the likes of AstraZeneca and Sarepta Therapeutics.

Trey Thoelcke | May 5, 2016 at 7:35 AM EDT

3 Big Pharma Stocks With Credible Threats to Their Blockbusters

A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an…

Sam Stebbins | Apr 26, 2016 at 6:57 AM EDT

The World’s 15 Top Selling Drugs

Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also…

Chris Lange | Mar 29, 2016 at 11:55 AM EDT

Inovio Fails to Impress With HPV Business Update

Inovio Pharmaceuticals made waves early on Tuesday morning following an update for its human papillomavirus (HPV) treatment.

Paul Ausick | Mar 22, 2016 at 4:04 PM EDT

The 52-Week Low Club for Tuesday

March 22, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in…

Jon C. Ogg | Mar 15, 2016 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AstraZeneca, 3D Systems, Barrick Gold, Home Depot, Oasis Petroleum, Whiting Petroleum and More

Tuesday's top analyst initiations, upgrades and downgrades include AstraZeneca, 3D Systems, Barrick Gold, Home Depot, Oasis Petroleum and Whiting Petroleum.

Trey Thoelcke | Feb 19, 2016 at 7:10 AM EST

AstraZeneca Gets European Approval for Heart Attack, Gout Treatments

AstraZeneca has announced that the European Commission granted marketing authorization for two of its treatments: Zurampic for gout and Brilique…

Jon C. Ogg | Feb 8, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK, Tableau and Many More

The top analyst upgrades, downgrades and initiations seen on Monday, February 8 include Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK and…

Jon C. Ogg | Jan 19, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: IBM, Lennar, Regions, Shake Shack, Shopify, TerraForm, McDonald’s and Many More

Stocks tanked on Friday but were indicated sharply higher on Tuesday after the three-day weekend and after China’s gross domestic…

Jon C. Ogg | Dec 23, 2015 at 7:45 AM EST

Why Breakthrough FDA Approval of Gout Treatment May Matter So Much

Good news for those who suffer from high levels of uric acid and from gout: the FDA has approved a…

Chris Lange | Nov 18, 2015 at 9:10 AM EST

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Jefferies has updated the thesis behind its "Top 5 for 2015" pharmaceutical stock picks

Jon C. Ogg | Nov 11, 2015 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Aegerion, Amazon, EMC, McDonald’s, MetLife, Microsoft, SanDisk, Tyco and More

Wednesday's top analyst upgrades, downgrades and initiations include Aegerion Pharmaceuticals, Amazon.com, EMC, McDonald's, MetLife, Microsoft, SanDisk and Tyco International.

1 … 6 7 8 9 10 … 15

AstraZeneca : AZN

All AstraZeneca Articles

Top Analyst Upgrades and Downgrades: Accenture, Cognizant Tech, Fitbit, Oracle, Seagate, Vodafone and Many More

10 Stocks to Win or Lose From Brexit Vote Outcome

8 Stocks on the Move After ASCO Cancer Abstracts

4 Major FDA Decisions Expected by June

3 Big Pharma Stocks With Credible Threats to Their Blockbusters

The World’s 15 Top Selling Drugs

Inovio Fails to Impress With HPV Business Update

The 52-Week Low Club for Tuesday

Top Analyst Upgrades and Downgrades: AstraZeneca, 3D Systems, Barrick Gold, Home Depot, Oasis Petroleum, Whiting Petroleum and More

AstraZeneca Gets European Approval for Heart Attack, Gout Treatments

Top Analyst Upgrades and Downgrades: Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK, Tableau and Many More

Top Analyst Upgrades and Downgrades: IBM, Lennar, Regions, Shake Shack, Shopify, TerraForm, McDonald’s and Many More

Why Breakthrough FDA Approval of Gout Treatment May Matter So Much

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Top Analyst Upgrades and Downgrades: Aegerion, Amazon, EMC, McDonald’s, MetLife, Microsoft, SanDisk, Tyco and More

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

AstraZeneca : AZN

All AstraZeneca Articles

Top Analyst Upgrades and Downgrades: Accenture, Cognizant Tech, Fitbit, Oracle, Seagate, Vodafone and Many More

10 Stocks to Win or Lose From Brexit Vote Outcome

8 Stocks on the Move After ASCO Cancer Abstracts

4 Major FDA Decisions Expected by June

3 Big Pharma Stocks With Credible Threats to Their Blockbusters

The World’s 15 Top Selling Drugs

Inovio Fails to Impress With HPV Business Update

The 52-Week Low Club for Tuesday

Top Analyst Upgrades and Downgrades: AstraZeneca, 3D Systems, Barrick Gold, Home Depot, Oasis Petroleum, Whiting Petroleum and More

AstraZeneca Gets European Approval for Heart Attack, Gout Treatments

Top Analyst Upgrades and Downgrades: Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK, Tableau and Many More

Top Analyst Upgrades and Downgrades: IBM, Lennar, Regions, Shake Shack, Shopify, TerraForm, McDonald’s and Many More

Why Breakthrough FDA Approval of Gout Treatment May Matter So Much

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Top Analyst Upgrades and Downgrades: Aegerion, Amazon, EMC, McDonald’s, MetLife, Microsoft, SanDisk, Tyco and More

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not